Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Monson, Nancy L ^a   Ortega, Sterling B ^a   Ireland, Sara J ^a   Meeuwissen, Anouk J M ^a   Chen, Ding ^a   Plautz, Erik J ^a   Shubel, Erin ^a   Kong, Xiangmei ^a   Li, Min K ^a   Freriks, Laura H ^a   Stowe, Ann M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B cells; B10; CXCL13; Hypoxic preconditioning; Neuroprotection; Stroke

Indexed keywords

CXCL13 CHEMOKINE; MESSENGER RNA;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BRAIN BLOOD VESSEL; BRAIN TISSUE; CD19+ B LYMPHOCYTE; CELL INTERACTION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; DIAPEDESIS; DOWN REGULATION; GENE EXPRESSION; IMMUNOPHENOTYPING; ISCHEMIC PRECONDITIONING; MACROPHAGE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; REPETITIVE HYPOXIC PRECONDITIONING; SPLEEN CELL; T LYMPHOCYTE; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; ENDOTHELIUM; FLOW CYTOMETRY; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; MICE; MICROARRAY ANALYSIS; PHOSPHOPYRUVATE HYDRATASE; TIME FACTORS;

EID: 84893179635     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-22     Document Type: Article

References (62)

1. Stowe AM, Altay T, Freie AB, Gidday JM. Repetitive hypoxia extends endogenous neurovascular protection for stroke. Ann Neurol 2011, 69:975-985. 10.1002/ana.22367, 3117913, 21437933.
2. Gavins F, Yilmaz G, Granger DN. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 2007, 14:667-681. 10.1080/10739680701404903, 17885993.
3. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66:232-245. 10.1016/j.surneu.2005.12.028, 16935624.
4. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857. 10.1161/STROKEAHA.108.534503, 19265055.
5. Stowe AM, Wacker BK, Cravens PD, Perfater JL, Li MK, Hu R, Freie AB, Stuve O, Gidday JM. CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke. J Neuroinflammation 2012, 9:33. 10.1186/1742-2094-9-33, 3298779, 22340958.
6. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, Offner H. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 2011, 31:8556-8563. 10.1523/JNEUROSCI.1623-11.2011, 3111929, 21653859.
7. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis 2013, 28:375-386. 10.1007/s11011-013-9413-3, 23640015.
8. Chen Y, Bodhankar S, Murphy SJ, Vandenbark AA, Alkayed NJ, Offner H. Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis 2012, 27:487-493. 10.1007/s11011-012-9317-7, 3427715, 22618587.
9. Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res 2012, 3:324-330. 10.1007/s12975-012-0187-4, 3501272, 23175646.
10. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113:2105-2112. 10.1161/CIRCULATIONAHA.105.593046, 16636173.
11. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol 2012, 8:401-410. 10.1038/nrneurol.2012.98, 22664787.
12. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, Austinat M, Nieswandt B, Wiendl H, Stoll G. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010, 115:3835-3842. 10.1182/blood-2009-10-249078, 20215643.
13. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, Iwakura Y, Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009, 15:946-950. 10.1038/nm.1999, 19648929.
14. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A, Sommer C, Dalpke AH, Veltkamp R. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 2011, 134:704-720. 10.1093/brain/awr008, 21354973.
15. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
16. Gelderblom H, Londono D, Bai Y, Cabral ES, Quandt J, Hornung R, Martin R, Marques A, Cadavid D. High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J Neuropathol Exp Neurol 2007, 66:208-217. 10.1097/01.jnen.0000248556.30209.6d, 17356382.
17. Ramesh G, Borda JT, Gill A, Ribka EP, Morici LA, Mottram P, Martin DS, Jacobs MB, Didier PJ, Philipp MT. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation 2009, 6:23. 10.1186/1742-2094-6-23, 2748066, 19706181.
18. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011, 17:796-808. 10.1038/nm.2399, 3137275, 21738161.
19. Monson NL, Cravens P, Hussain R, Harp CT, Cummings M, De Pilar Martin M, Ben LH, Do J, Lyons JA, Lovette-Racke A, Cross AH, Racke MK, Stuve O, Shlomchik M, Eagar TN. Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. PLoS One 2011, 6:e17103. 10.1371/journal.pone.0017103, 3040191, 21359213.
20. Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol 2013, 131:959-971. 10.1016/j.jaci.2013.01.046, 23465663.
21. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008, 20:149-157. 10.1016/j.coi.2008.03.014, 2532490, 18434123.
22. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001, 167:6834-6840.
23. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650. 10.1016/j.immuni.2008.03.017, 18482568.
24. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482. 10.1038/82717, 11101868.
25. Ortega SB, Kashi VP, Tyler AF, Cunnusamy K, Mendoza JP, Karandikar NJ. The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J Immunol 2013, 191:117-126. 10.4049/jimmunol.1300452, 23733879.
26. Li ZM, Huang JJ, Xia Y, Sun J, Huang Y, Wang Y, Zhu YJ, Li YJ, Zhao W, Wei WX, Lin TY, Huang HQ, Jiang WQ. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One 2012, 7:e41658. 10.1371/journal.pone.0041658, 3402437, 22911837.
27. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Boddeker I, Oertel WH, Sommer N, Hemmer B. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001, 124:2169-2176. 10.1093/brain/124.11.2169, 11673319.
28. Nagarajan UM, Lochamy J, Chen X, Beresford GW, Nilsen R, Jensen PE, Boss JM. Class II transactivator is required for maximal expression of HLA-DOB in B cells. J Immunol 2002, 168:1780-1786.
29. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005, 23:487-513. 10.1146/annurev.immunol.23.021704.115732, 15771579.
30. Garraud O, Borhis G, Badr G, Degrelle S, Pozzetto B, Cognasse F, Richard Y. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol 2012, 13:63. 10.1186/1471-2172-13-63, 3526508, 23194300.
31. Wolf SD, Dittel BN, Hardardottir F, Janeway CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278. 10.1084/jem.184.6.2271, 2196394, 8976182.
32. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010, 185:2240-2252. 10.4049/jimmunol.1001307, 3717968, 20624940.
33. Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005, 25:29-40. 10.1007/s10875-005-0355-6, 15742155.
34. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140. 10.1016/j.immuni.2009.11.009, 20079667.
35. Watanabe R, Tomita N, Itabashi M, Ishibashi D, Yamamoto E, Koyama S, Miyashita K, Takahashi H, Nakajima Y, Hattori Y, Motohashi K, Takasaki H, Ohshima R, Hashimoto C, Yamazaki E, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. Eur J Haematol 2013,
36. Planas AM, Gorina R, Chamorro A. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem Soc Trans 2006, 34:1267-1270. 10.1042/BST0341267, 17073799.
37. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994, 152:3559-3569.
38. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4 + CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007, 178:3447-3456.
39. Pils MC, Pisano F, Fasnacht N, Heinrich JM, Groebe L, Schippers A, Rozell B, Jack RS, Muller W. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 2010, 40:443-448. 10.1002/eji.200939592, 19941312.
40. Anthony DC, Couch Y, Losey P, Evans MC. The systemic response to brain injury and disease. Brain Behav Immun 2012, 26:534-540. 10.1016/j.bbi.2011.10.011, 22085588.
41. Becker KJ. Sensitization and tolerization to brain antigens in stroke. Neuroscience 2009, 158:1090-1097. 10.1016/j.neuroscience.2008.07.027, 2684331, 18706487.
42. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, McEwen BS, Iadecola C, Bulloch K. Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav Immun 2010, 24:724-737. 10.1016/j.bbi.2009.11.002, 2885548, 19914372.
43. Planas AM, Gomez-Choco M, Urra X, Gorina R, Caballero M, Chamorro A. Brain-derived antigens in lymphoid tissue of patients with acute stroke. J Immunol 2012, 188:2156-2163. 10.4049/jimmunol.1102289, 22287710.
44. Gee JM, Zierath D, Hadwin J, Savos A, Kalil A, Thullbery M, Becker KJ. Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med 2009, 1:3. 10.1186/2040-7378-1-3, 2816867, 20142990.
45. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Gohler J, Bereswill S, Gobel U, Wernecke KD, Wolf T, Arnold G, Halle E, Volk HD, Dirnagl U, Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008, 3:e2158. 10.1371/journal.pone.0002158, 2373885, 18478129.
46. Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev 2012, 247:52-63. 10.1111/j.1600-065X.2012.01124.x, 22500831.
47. Nguyen TG, Little CB, Yenson VM, Jackson CJ, McCracken SA, Warning J, Stevens V, Gallery EG, Morris JM. Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance. J Autoimmun 2010, 35:86-97. 10.1016/j.jaut.2010.03.003, 20456921.
48. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358:676-688. 10.1056/NEJMoa0706383, 18272891.
49. Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 2008, 63:395-400. 10.1002/ana.21363, 18383069.
50. Chung JB, Wells AD, Adler S, Jacob A, Turka LA, Monroe JG. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness. J Immunol 2003, 171:1758-1767.
51. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430. 2542851, 18802481.
52. Cariappa A, Chase C, Liu H, Russell P, Pillai S. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood 2007, 109:2339-2345. 10.1182/blood-2006-05-021089, 17119110.
53. Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 2008, 173:1415-1427. 10.2353/ajpath.2008.080483, 2570132, 18832582.
54. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P, Kusser K, Hopken UE, Lipp M, Niederreither K, Blomhoff R, Sitnik K, Agace WW, Randall TD, de Jonge WJ, Mebius RE. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol 2009, 10:1193-1199. 10.1038/ni.1789, 2771164, 19783990.
55. Edling AE, Nanavati T, Johnson JM, Tuohy VK. Human and murine lymphocyte neurotrophin expression is confined to B cells. J Neurosci Res 2004, 77:709-717. 10.1002/jnr.20176, 15352217.
56. Fauchais AL, Lalloue F, Lise MC, Boumediene A, Preudhomme JL, Vidal E, Jauberteau MO. Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 2008, 181:3027-3038.
57. Begum-Haque S, Christy M, Ochoa-Reparaz J, Nowak EC, Mielcarz D, Haque A, Kasper LH. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate. J Neuroimmunol 2011, 232:136-144. 10.1016/j.jneuroim.2010.10.031, 3753076, 21111489.
58. Faeh D, Gutzwiller F, Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 2009, 120:495-501. 10.1161/CIRCULATIONAHA.108.819250, 19635973.
59. Krarup LH, Truelsen T, Gluud C, Andersen G, Zeng X, Korv J, Oskedra A, Boysen G. Prestroke physical activity is associated with severity and long-term outcome from first-ever stroke. Neurology 2008, 71:1313-1318. 10.1212/01.wnl.0000327667.48013.9f, 18936423.
60. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007, 116:I98-I105.
61. Shimizu M, Saxena P, Konstantinov IE, Cherepanov V, Cheung MM, Wearden P, Zhangdong H, Schmidt M, Downey GP, Redington AN. Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. J Surg Res 2010, 158:155-161. 10.1016/j.jss.2008.08.010, 19540519.
62. Zhou W, Zeng D, Chen R, Liu J, Yang G, Liu P, Zhou X. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 2010, 31:22-29. 10.1007/s00246-009-9536-9, 19787388.